スポンサーリンク
Department of Hepatology and Okinaka Memorial Institute for Medical Research, Toranomon Hospital | 論文
- Efficacy and Safety of Combination Therapy of Natural Human Interferon β and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load
- Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
- The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load